Loading data
AVIRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | 351.37 m USD |
| Research and development expense | 148.02 m USD | 144.1 m USD | 114.24 m USD | 81.94 m USD | 167.21 m USD |
| Operating profit | -180.89 m USD | -192.95 m USD | -164.16 m USD | -130.65 m USD | 138.38 m USD |
| Profit before tax | -164.51 m USD | -167.46 m USD | -134.94 m USD | -119.5 m USD | 138.59 m USD |
| Income tax expense | -6.16 m USD | 925 k USD | 1.02 m USD | -3.59 m USD | 17.4 m USD |
| Net income (reported basis) | -158 m USD | -168 m USD | -136 m USD | -116 m USD | 121 m USD |
| Basic earnings per share | -1.94 USD/share | -2 USD/share | -1.63 USD/share | -1.39 USD/share | 1.46 USD/share |
| Diluted earnings per share | -1.94 USD/share | -2 USD/share | -1.63 USD/share | -1.39 USD/share | 1.37 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.